Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists

JANX - Janux Therapeutics, Inc. Stock Price, Fair Value and News

$30.65-0.70 (-2.23%)
Delayed
Max Portfolio Pct.
Check
Valuation
Check

Stock Quality:

GPSDBMFI
Max Portfolio Pct.
Check
Valuation
Check
GPSDBMFI

NSPR Price Action

Last 7 days

-1.4%

Last 30 days

-0.4%

Last 90 days

-5.1%

Trailing 12 Months

16.7%

NSPR RSI Chart

JunJulAugSepOctNovDec2025FebMar020406080100

NSPR Valuation

Market Cap

83.1M

Price/Earnings (Trailing)

-2.6

Price/Sales (Trailing)

11.86

EV/EBITDA

0.26

Price/Free Cashflow

-3.57

NSPR Price/Sales (Trailing)

20222023202420252468101214

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

NSPR Fundamentals

NSPR Revenue

Revenue (TTM)

7.0M

Rev. Growth (Yr)

10.68%

Rev. Growth (Qtr)

7.68%

201020122014201620182020202220242M3M4M5M6M7M

NSPR Earnings

Earnings (TTM)

-32.0M

Earnings Growth (Yr)

-69.73%

Earnings Growth (Qtr)

-16.27%

20102012201420162018202020222024-35M-30M-25M-20M-15M-10M-5M0

NSPR Profitability

Operating Margin

65.33%

EBT Margin

-455.79%

Return on Equity

-88.69%

Return on Assets

-68.38%

Free Cashflow Yield

-27.99%

NSPR Investor Care

Shares Dilution (1Y)

26.57%

Diluted EPS (TTM)

-0.76

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
201020122014201620182020202220242M3M4M5M6M7M
Net sales
YearQ1Q2Q3Q4
20246.5M6.6M6.8M7.0M
20235.2M5.3M5.5M6.2M
20224.7M5.2M5.5M5.2M
20212.5M3.2M3.3M4.5M
20204.3M3.3M3.3M2.5M
20193.0M3.4M3.5M3.7M
20183.2M3.6M3.6M3.6M
20171.9M2.0M2.2M2.8M
20162.4M2.3M2.1M1.9M
20151.8M2.3M2.7M2.3M
20146.1M4.8M3.5M2.8M
20134.3M4.9M5.9M6.1M
20125.5M5.3M3.9M3.9M
20114.5M4.7M5.4M6.0M
201003.9M4.4M4.9M
20090003.4M
Get all data in R, Python etc through our Historical Stock Data APIs

About InspireMD Inc

InspireMD, Inc., a medical device company, focuses on the development and commercialization of MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Delivery System, a mesh-covered self-expanding carotid stent; SwitchGuard, a non-invasive transcarotid artery revascularization device; and NGuard EPS for treating acute stroke with tandem lesions. The company sells its products through local distribution partners. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.
 CEO
 WEBSITEinspiremd.com
 SECTORHealthcare
 INDUSTRYMedical Devices
 EMPLOYEES55

InspireMD Inc Frequently Asked Questions

What is the ticker symbol for InspireMD Inc? What does NSPR stand for in stocks?

NSPR is the stock ticker symbol of InspireMD Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of InspireMD Inc (NSPR)?

As of Fri Mar 14 2025, market cap of InspireMD Inc is 83.13 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of NSPR stock?

You can check NSPR's fair value in chart for subscribers.

Is InspireMD Inc a good stock to buy?

The fair value guage provides a quick view whether NSPR is over valued or under valued. Whether InspireMD Inc is cheap or expensive depends on the assumptions which impact InspireMD Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for NSPR.

What is InspireMD Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Mar 14 2025, NSPR's PE ratio (Price to Earnings) is -2.6 and Price to Sales (PS) ratio is 11.86. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. NSPR PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on InspireMD Inc's stock?

In the past 10 years, InspireMD Inc has provided -0.631 (multiply by 100 for percentage) rate of return.